-
SALSA® digital Multiplex Ligation-dependent Probe Amplification (digitalMLPA) is a multiplex PCR followed by Illumina sequencing-based amplicon quantification, for the detection of copy number variations (CNV) and specific point mutations.
ADD TO SHORTLIST -
Methylation-Specific (MS)-MLPA® is a variant of the MLPA technique, the gold standard in copy number determination. With MS-MLPA, it is possible to semi-quantitatively profile methylation for multiple targets simultaneously.
ADD TO SHORTLIST -
MLPA Assays are useful in finding out those who have Lung Disorders
ADD TO SHORTLIST -
MLPA Assays are useful in finding out those who have cardiovascular diseases.
ADD TO SHORTLIST -
MLPA Assays are useful in finding out those who have hereditary blood disorders.
ADD TO SHORTLIST -
-
MLPA Assays are useful in finding out those who have Skeletal & Connective Tissue Disorders
ADD TO SHORTLIST -
MLPA Assays are useful in tumor profiling for blood cancer, solid tumors as well as general tumor profiling
ADD TO SHORTLIST -
The SALSA digitalMLPAProbemix D006-A1 Multiple Myeloma is a research use only (RUO) assay for the detection of deletions, gains or amplifications of genes and chromosomal regions mentioned in Table 2 that are recurrently altered in multiple myeloma, such as 1p, 1q, 13q and 17p, as well as for the detection of BRAF p.V600E point mutation.
ADD TO SHORTLIST -
The SALSA digitalMLPA Probemix D007-A1 Acute lymphocytic leukemia is a research-use-only (RUO) assay for the detection of deletions, gains or amplifications in 52 specific target genes and three chromosomal regions (5q, iAMP21 and PAR1), which are related to acute lymphoblastic leukemia (ALL).
ADD TO SHORTLIST -
SALSA® Melt Assays are designed for the fast and reliable screening of a small number of targets in a large number of samples.
ADD TO SHORTLIST
MRC-Holland Products in India
MRC Holland is a company based out of The Netherlands which has a proprietary technology - MLPA (Multiplex Ligation-dependant Probe Amplification (MLPA), a multiplex PCR method which enables detection of variation in copy number (CNV) of up to 60 DNA sequences in one reaction and can handle up to 96 DNA samples at a stretch with results being available within 24 hours.
Introduced in 2002, MLPA is a gold standard in CNV detection and has proven to be a robust and easy-to-use techniques, and since it is highly sensitive to even a single nucleotide difference, it has applications in detection of point mutations.
MLPA, when used in combination with a methylation-sensitive restriction enzyme, can be applied to detect DNA methylation patterns (MS_MLPA). The first Melt Assay for spinal muscular atrophy (SMA) newborn screening was launched in 2018 and the first digitalMLPA technique based assay was launched in 2020. digitalMLPA combines the trusted quality of MLPA with the power of next-generation sequencing to examine many more target sequences in a single reaction.
In diagnostics and research of both human genetic disorders and tumors, MLPA is used in laboratories worldwide.
